A comprehensive view of Prescription Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Inflation Reduction Act to reduce pharmaceutical industry revenue by 2% overall, with companies relying on Medicare sales, which account for 15% of global branded drug sales, to be affected most; Medicare negotiations could save US US$100B: Morningstar

Most medical device and drug makers with operations in Puerto Rico do not expect significant disruptions of supplies to US due to Hurricane Fiona; Hurricane Maria in 2017 caused many firms to be better prepared reports J.P. Morgan

Novartis focusing on becoming a top five drug maker in US market where it currently ranks tenth; company to increase share of US patients in clinical trials and build capability and talent in US

GSK spinoff Haleon rejects request from Pfizer, GSK to help pay for Zantac litigation; Haleon says its company structure when it was a Pfizer, GSK JV doesn’t require it to fund litigation expenses

Lannett and Par Pharmaceuticals join list of companies having difficulty supplying attention-deficit drug Adderall; shortage attributed to jump in prescriptions due to increase in diagnoses, expanded availability through online startups

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count